Interested in Cartistem Procedure? On this page, we have collected links for you, where you will receive the most necessary information about Cartistem Procedure.


CARTISTEM® - MEDIPOST

    http://www.medi-post.com/cartistem/
    CARTISTEM® – allogeneic umbilical cord blood-derived mesenchymal stem cells, is used for the treatment of knee cartilage defects in patients with Osteoarthritis (with ICRS grade* IV cartilage defect) caused by degeneration or repetitive trauma. *ICRS …

CARTISTEM IMPLANTATION OF FEMORAL CONDYLE …

    https://www.briancolemd.com/wp-content/themes/ypo-theme/pdf/cartistem-implantation-femoral-condyle.pdf
    CARTISTEM IMPLANTATION OF FEMORAL CONDYLE REHABILITATION PROTOCOL ! COPYRIGHT*2014*CRC*©BRIAN*J.*COLE,*MD,*MBA WEIGHT BEARING BRACE ROM EXERCISES PHASE I 0-6 weeks Non-WB 0-2 week: Locked in full extension at all times Off for CPM and exercise only Discontinue after 2 wks 0-6 weeks: Use CPM for 6 hours/day, beginning at 0-40°; advance 5-

Efficacy and Safety of Allogenic Stem Cell Product ...

    https://clinicaltrials.gov/ct2/show/NCT04310215
    Mar 17, 2020 · Procedure: Microfracture Biological: CARTISTEM® (Human Umbilical Cord Blood-derived Mesenchymal Stem Cell product)

Study to Compare Efficacy and Safety of Cartistem and ...

    https://clinicaltrials.gov/ct2/show/NCT01041001
    Dec 30, 2009 · A few life science companies both home and abroad are marketing this method of treatment called 'autologous chondrocyte transplant'. The treatment involves the extraction of healthy cartilage tissue from the patient which is then cultured and transplanted into the damaged site.

Follow-Up Study of CARTISTEM® Versus Microfracture for the ...

    https://clinicaltrials.gov/ct2/show/NCT01626677
    Jun 25, 2012 · Biological: CARTISTEM Procedure: Microfracture. Phase 3. Detailed Description: This long term follow-up study is performed to assess the long-term safety and efficacy of CARTISTEM®, human umbilical cord blood-derived mesenchymal stem cells, in repair of cartilage injury or defects, compared with microfracture.

What Is the Cost of Cartistem? Stem Cells Freak

    http://stemcellsfreak.com/2015/01/cartistem-price.html
    In general, cartistem is a relatively expensive treatment that is yet not covered by insurance companies. Expect to pay somewhere in the $20,000* range for the standard treatment and an additional $10,000 for every extra treatment. This price is only for one knee and doesn't include hospital stay (~1 week), airplane tickets, food expenses and anything else that might come up.

Knee arthroscopy stem cell therapy - YouTube

    https://www.youtube.com/watch?v=AONjRQtTINA
    Oct 25, 2017 · Dr. Laith Farjo discusses the state-of-the-art treatment of knee arthritis with stem cell therapy and arthroscopy. Not only can this improve your symptoms in...Author: laithfarjomd

orthopedic applications of stem cell therapy

    https://www.bluecrossnc.com/sites/default/files/document/attachment/services/public/pdfs/medicalpolicy/orthopedic_applications_of_stem_cell_therapy.pdf
    Cartistem ®, a combination of human umbilical cord blood-derived mesenchymal stem cells and sodium hyaluronate, is intended to be used as a single-dose therapeutic agent for cartilage regeneration in humans with cartilage defects of the knee as a result of aging, trauma, or degenerative diseases. A

MEDIPOST Initiates Phase-2 Clinical Trial of CARTISTEM in ...

    http://www.medi-post.com/stem-cell-therapeutic/2019/12/36431/
    MEDIPOST Receives Approval for Phase III Clinical Trial of CARTISTEM for the Treatment of Osteochondral Cartilage Defects in Ankle Joint. 2019/12/03. STEM CELL THERAPEUTIC. Allogeneic cell therapy product CARTISTEM ® will undergo a Phase 3 clinical trial to expand indications. MEDIPOST announced on the 3 rd of this month that the Ministry of Food and Drug Safety (MFDS) …

Evaluation of Safety and Exploratory Efficacy of CARTISTEM ...

    https://clinicaltrials.gov/ct2/show/NCT01733186
    Nov 26, 2012 · CARTISTEM®, a combination of human umbilical cord blood-derived mesenchymal stem cells and sodium hyaluronate, is intended to be used as a single-dose cellular therapeutic agent for cartilage regeneration in human subjects with cartilage defects of the knee as a result of ageing, trauma, or degenerative diseases.

We hope you have found all the information you need about Cartistem Procedure through the links above.


Previous -------- Next

Related Pages